{"contacts": [{"terms": [{"accession": "MS:1002037", "name": "dataset submitter"}, {"accession": "MS:1000586", "name": "contact name", "value": "Aaron Goldman"}, {"accession": "MS:1000589", "name": "contact email", "value": "agoldman@wistar.org"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "The Wistar Institute"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "David W. Speicher"}]}], "description": "ARID1A, which encodes a component of the SWI/SNF chromatin-remodeling complex, is commonly mutated in ovarian clear cell carcinoma and many other cancer types. We used label-free LC-MS/MS to identify ARID1A-dependent proteome changes in ovarian clear cell carcinoma cell lines. In our first analysis, we compared ARID1A-wildtype ovarian clear cell carcinoma cell line OVCA429 with or without ARID1A CRISPR knockout. In a complementary analysis, we compared ARID1A-mutated ovarian clear cell carcinoma cell line OVISE with or without ARID1A overexpression using a tet-inducible promoter.", "fullDatasetLinks": [{"accession": "MS:1002488", "name": "MassIVE dataset URI", "value": "http://massive.ucsd.edu/ProteoSAFe/status.jsp?task=f4ce3960a87445f9a73ee05bfcad41a5"}, {"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://massive.ucsd.edu/MSV000079904"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD004570"}, {"accession": "MS:1002487", "name": "MassIVE dataset identifier", "value": "MSV000079904"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Ovarian clear cell carcinoma"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "ARID1A"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "BAF250a"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "SWI/SNF chromatin-remodeling complex"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "Ovarian cancer"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "Cancer"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "Human"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "LC-MS/MS"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "Epithelial ovarian cancer"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "Label-free quantitation"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "OVCA429"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "OVISE"}], "modifications": [{"accession": "UNIMOD:1", "name": "Acetyl"}, {"accession": "UNIMOD:35", "name": "Oxidation"}, {"accession": "UNIMOD:4", "name": "Carbamidomethyl"}], "publications": [{"terms": [{"accession": "PRIDE:0000400", "name": "Reference", "value": "     Aaron R. Goldman, Benjamin G. Bitler, Zachary Schug, Jose R. Conejo-Garcia, Rugang Zhang, and David W. Speicher. The Primary Effect on the Proteome of ARID1A-Mutated Ovarian Clear Cell Carcinoma is Downregulation of the Mevalonate Pathway at the Post-Transcriptional Level. Mol Cell Proteomics mcp.M116.062539. First Published on September 21, 2016, doi:10.1074/mcp.M116.062539."}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens"}, {"accession": "MS:1001468", "name": "taxonomy: common name", "value": "human"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Proteome analyses of two ovarian clear cell carcinoma cell lines with or without ARID1A manipulation"}